Susceptibility for ischemic stroke in Four Constitution medicine is associated with polymorphisms of FCGR2A and IL1RN genes

Neurological Research

Volumn 32, Issue SUPPL.1, 2010, Pages

  Lee, Byung Cheol ^a   Lee, Hyejung ^a   Park, Hun Kuk ^b   Yang, Jong Soo ^b   Chung, Joo Ho ^a  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

FCGR2A; Four Constitution medicine; Interleukin 1 receptor antagonist; Ischemic stroke; Polymorphism

Indexed keywords

FC RECEPTOR IIA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; STROKE PATIENT;

ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN ISCHEMIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; KOREA; MALE; MEDICINE, KOREAN TRADITIONAL; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREVALENCE; QUESTIONNAIRES; RECEPTORS, IGG; SEQUENCE ANALYSIS, DNA; STROKE;

EID: 77949434149     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164109x12537002793922     Document Type: Article

References (25)

1. Lee JM. Longevity and Life Preservation in Oriental Medicine, trans. by Choi SH, Seoul: Kyung Hee University Press, 1996
2. Chae H, Lyoo IK, Lee SJ, et al. An alternative way to individualized medicine: Psychological and physical traits of Sasang typology. J Altern Complement Med 2003; 9: 519-528
3. Um JY, Joo JC, Kim KY, et al. Angiotensin converting enzyme gene polymorphism and traditional Sasang classification in Koreans with cerebral infarction. Hereditas 2003; 138: 166-171
4. Hopkins SJ, Rothwell NJ. Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci 1995; 18: 83-88
5. Geng YJ, Wu Q, Muszynski M, et al. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferongamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol 1996; 16: 19-27
6. Ravetch JV. Fc receptors: Rubor redux. Cell 1994; 78: 553-560
7. Sylvestre DL, Ravetch JV. Fc receptors initiate the Arthus reaction: Redefining the inflammatory cascade. Science 1994; 265: 1095-1098
8. Pfeiffer JR, Howes PS, Waters MA, et al. Levels of expression of Fcgamma receptor IIA (CD32) are decreased on peripheral blood monocytes in patients with severe atherosclerosis. Atherosclerosis 2001; 155: 211-218
9. Rothe G, Gabriel H, Kovacs E, et al. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler Thromb Vasc Biol 1996; 16: 1437-1447
10. van der Meer IM, Witteman JC, Hofman A, et al. Genetic variation in Fcgamma receptor IIa protects against advanced peripheral atherosclerosis. The Rotterdam Study. Thromb Haemost 2004; 92: 1273-1276
11. Morgan AW, Robinson JI, Barrett JH, et al. Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis. Arthritis Res Ther 2006; 8: R109
12. Harley JB, Alarcon-Riquelme ME, Criswell LA, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 40: 204-210
13. Sinha S, Mishra SK, Sharma S, et al. Polymorphisms of TNFenhancer and gene for FcgammaRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population. Malar J 2008; 7: 13
14. Ozturk C, Aksu G, Berdeli A, et al. Fc gamma RIIa, IIIa and IIIb polymorphisms in Turkish children susceptible to recurrent infectious diseases. Clin Exp Med 2006; 6: 27-32
15. Hannum CH, Wilcox CJ, Arend WP, et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990; 343: 336-340
16. Giovine FS, Takhsh E, Blakemore AI, et al. Single base polymorphism at 2511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1992; 1: 450
17. Garcia JH, Liu KF, Relton JK. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol 1995; 147: 1477-1486
18. Tarlow JK, Blakemore AI, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91: 403-404
19. Shu KH, Lee SH, Cheng CH, et al. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy. Kidney Int 2000; 58: 783-789
20. Lee BC, Ahn SY, Doo HK, et al. Susceptibility for ischemic stroke is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor- genes, but not the interleukin-1 gene. Neurosci Lett 2004; 357: 33-36
21. Joseph KK. Compass of Health: Using the Art of SasangMedicine to Maximize Your Health, Franklin Lakes, NJ: Career Press, 2001
22. Ratcliffe NR, Kennedy SM, Morganelli PM. Immunocytochemical detection of Fcgamma receptors in human atherosclerotic lesions. Immunol Lett 2001; 77: 169-174
23. van de Winkel JG, Anderson CL. Biology of human immunoglobulin G Fc receptors. J Leukoc Biol 1991; 49: 511-524
24. Huang Y, Fleming AJ, Wu S, et al. Fc-gamma receptor cross-linking by immune complexes induces matrix metalloproteinase-1 in U937 cells via mitogen-activated protein kinase. Arterioscler Thromb Vasc Biol 2000; 20: 2533-2538
25. Lin RC, Morris BJ. Association analysis of polymorphisms at the interleukin-1 locus in essential hypertension. Am J Med Genet 2002; 107: 311-316